This inventor holds 2 USPTO granted patents. Top assignees: Boman (Zhejiang) Biotechnology Co., Ltd., Zhejiang Gllion Bioscience Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Hongliang Guo in Biological Polysaccharides
Introduction
Hongliang Guo is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of biological polysaccharides, particularly in the area of dermatological applications. His work focuses on developing compositions that can prevent and treat hormone-dependent dermatitis and other skin inflammatory diseases.
Latest Patents
Hongliang Guo holds a patent for a biological polysaccharide that has shown effectiveness in preventing and treating hormone-dependent dermatitis. The patent describes a composition that contains β-glucan, which is utilized for its therapeutic properties against skin mucositis and other inflammatory skin conditions. This innovation highlights the potential of natural compounds in medical treatments.
Career Highlights
Guo is associated with Zhejiang Gllion Bioscience Co., Ltd., where he continues to advance research in biosciences. His work at the company emphasizes the importance of innovative solutions in healthcare and dermatology. With a focus on practical applications, Guo's contributions are paving the way for new treatment options.
Collaborations
Hongliang Guo collaborates with esteemed colleagues such as Xiuyuan Zhuang and Binnian Zhu. Their combined expertise enhances the research and development efforts at Zhejiang Gllion Bioscience Co., Ltd. Together, they are working towards breakthroughs in the field of biological sciences.
Conclusion
Hongliang Guo's innovative work in biological polysaccharides represents a significant advancement in the treatment of skin conditions. His patent and ongoing research contribute to the growing field of dermatological therapies. The impact of his work is expected to benefit many individuals suffering from skin inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile